 treatment relaps non-hodgkin lymphoma dexamethason high-dos cytarabin cisplatin marrow transplant combin chemotherapi capabl mani patient intermediate- high-grad non-hodgkin lymphoma nhl treatment relaps nhl problemat bone marrow transplant bmt chanc disease-fre surviv interim chemotherapi necessari bmt patient bulki diseas patient median age year primari therapi doxorubicin-bas regimen cycl dexamethason mg intraven IV day day cisplatin continu infus day IV hour dose day dhap bmt histolog diffus large-cel diffus mix diffus small-cleav lymphoblast twenty-eight patient stage IV diseas symptom elev lactat dehydrogenas ldh patient median previou chemotherapi regimen percent patient high tumor MD anderson criteria object respons dhap patient complet respons cr partial respons pr respons median month myelosuppress major toxic treatment-rel death date patient undergon subsequ bmt disease-fre surviv dhap regimen effect short-term salvag therapi relaps nhl patient long-term prognosi multipli relaps patient poor